cynaropicrin has been researched along with African Sleeping Sickness in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, M; Becker, K; Brun, R; Hamburger, M; Kaiser, M; Krauth-Siegel, RL; Leroux, A; Oufir, M; Zimmermann, S | 1 |
| Adams, M; Brun, R; Hamburger, M; Kaiser, M; Zimmermann, S | 1 |
2 other study(ies) available for cynaropicrin and African Sleeping Sickness
| Article | Year |
|---|---|
Cynaropicrin targets the trypanothione redox system in Trypanosoma brucei.
Topics: Amide Synthases; Enzyme Activation; Humans; Lactones; NADH, NADPH Oxidoreductases; Ornithine Decarboxylase; Ornithine Decarboxylase Inhibitors; Oxidation-Reduction; Protozoan Proteins; Sesquiterpenes; Sulfhydryl Compounds; Trypanosoma brucei brucei; Trypanosomiasis, African | 2013 |
Cynaropicrin: the first plant natural product with in vivo activity against Trypanosoma brucei.
Topics: Animals; Cell Line; Centaurea; Disease Models, Animal; Female; Humans; Inhibitory Concentration 50; Injections, Intraperitoneal; Lactones; Mice; Molecular Structure; Parasitemia; Parasitic Sensitivity Tests; Plant Components, Aerial; Plant Extracts; Rats; Sesquiterpenes; Trypanocidal Agents; Trypanosoma brucei gambiense; Trypanosoma brucei rhodesiense; Trypanosomiasis, African | 2012 |